Cancer clinical trials in the region Occitanie

144 currently recruiting clinical trials
Region Occitanie

Phase 3 Lymphoma
#NCT05100862
B cell lymphoma Follicular lymphoma Marginal zone lymphoma Targeted therapy 1 2 3 or more
6 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
BeiGene
Phase 3 Liver and bile duct cancer
#NCT05301842
Hepatocellular carcinoma Localized Locally Advanced Unhealthy A
8 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre de Cancérologie du Grand Montpellier (Montpellier)
AstraZeneca
Phase 3 Liver and bile duct cancer
#NCT05078047
Hepatocellular carcinoma Metastatic Immunotherapy
6 main criterias to confirm
IUCT Oncopôle (Toulouse), CHU Nîmes / Institut de cancérologie du Gard (Nîmes), Institut Sainte Catherine (Avignon)
UNICANCER
Phase 3 Liver and bile duct cancer
#NCT05876754
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic IDH1/2
Transplant Systemic Treatment-Naive
7 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
Servier
Phase 3 Breast cancer
#NCT06016738
HER2 Negative HR Positive Locally Advanced Metastatic Targeted therapy Hormone therapy
Chemotherapy
8 main criterias to confirm
Centre de Cancérologie du Grand Montpellier (Montpellier)
Olema Pharmaceuticals, Inc.
Phase 3 Breast cancer
#NCT05952557
HER2 Negative HR Positive Localized Surgery Chemotherapy Radiotherapy Hormone therapy
Systemic Treatment-Naive
8 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre Hospitalier Universitaire de Nîmes (Nîmes)
AstraZeneca
Phase 3 Colon cancer Rectal cancer
#NCT06293625
Adenocarcinoma Locally Advanced MSS Systemic Treatment-Naive
MSI/dMMR
7 main criterias to confirm
Hôpital Jacques Puel - Bourran (Rodez), Clinique des Cèdres - Ramsay Santé (Cornebarrieu), Centre Hospitalier de Perpignan (Perpignan), Centre Hospitalier Henri Mondor (Aurillac), Centre Hospitalier Emile Roux (Le Puy-en-Velay) (and 1 more...)
CHU Dijon
Phase 3 Breast cancer
#NCT06112379
HER2 Negative HR Negative Locally Advanced Systemic Treatment-Naive
Immunotherapy Chemotherapy Targeted therapy Car-T Bispecific T-cell engager antibodies Radiotherapy Hormone therapy
8 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Institut du cancer de Montpellier (Montpellier), Centre Hospitalier d'Avignon (Avignon)
AstraZeneca
Phase 3 Lymphoma
#NCT06084936
B cell lymphoma Mantel cell lymphoma None 1 2 3 or more
Systemic Treatment-Naive Car-T Bispecific T-cell engager antibodies Allogeneic stem cell transplant
8 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
Hoffmann-La Roche